Patents by Inventor Anne Knecht

Anne Knecht has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions, Methods and Kits for Stabilizing Cells and Biological Samples
    Publication number: 20220104482
    Abstract: Compositions, methods and kits are described for stabilizing cells and biological samples, allowing for storage and transportation of stabilized cells and biological samples. Cells can be stabilized in whole blood or fractionated blood. Isolated cells can also be stabilized.
    Type: Application
    Filed: February 7, 2020
    Publication date: April 7, 2022
    Inventors: Mehmet Toner, Rebecca Sandlin, Anne Knecht, Ho Ki Wong, Shannon N. Tessier, Shannon Stott
  • Dorsal tissue affecting factor and compositions
    Publication number: 20020102643
    Abstract: Novel dorsal growth inducing factors, complexes including the factors, and DNA or RNA coding sequences for the factors are described.
    Type: Application
    Filed: July 2, 2001
    Publication date: August 1, 2002
    Inventors: David M. Valenzuela, Nancy Y. Ip, Henryk D. Cudny, George D. Yancopoulos, Richard M. Harland, William C. Smith, Teresa Lamb, Anne Knecht
  • Dorsal tissue affecting factor and compositions
    Patent number: 6277593
    Abstract: Novel dorsal growth inducing factors, complexes including the factors, and DNA or RNA coding sequences for the factors are described.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: August 21, 2001
    Assignees: Regeneron Pharmaceuticals, Inc., Regents of the Univ. of California
    Inventors: David M. Valenzuela, Nancy Y. Ip, Henryk D. Cudny, George D. Yancopoulos, Richard M. Harland, William C. Smith, Teresa Lamb, Anne Knecht
  • Human dorsal tissue affecting factor (noggin) and nucleic acids encoding same
    Patent number: 5843775
    Abstract: Novel dorsal growth inducing factors, complexes including the factors, and DNA or RNA coding sequences for the factors are described.
    Type: Grant
    Filed: September 22, 1995
    Date of Patent: December 1, 1998
    Assignees: Regeneron Pharmaceuticals, Inc., Regents of University of California
    Inventors: David M. Valenzuela, Nancy Y. Ip, Henryk D. Cudny, George D. Yancopoulos, Richard M. Harland, William C. Smith, Teresa Lamb, Anne Knecht